Sana Biotechnology Inc
SANA - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$709.48M
Close$
$-0.03
101.1% downside
Current Fair Value
101.1% downsideOvervalued by 101.1% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $709.48 Million |
|---|---|
| Enterprise Value | $722.22 Million |
| Earnings per Share | $-0.96 |
| Beta | 2.19 |
| Outstanding Shares | 307,002,000 |
Return
| Return on Equity | -82.76% |
|---|---|
| Return on Assets | -39.69% |
| Return on Invested Capital | -45.02% |
Valuation & Multiples
| P/E Ratio | -4.47 |
|---|---|
| PEG | 3.01 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -5.33 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.3 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 5, 2026
EPS
$0.07
Est. -$0.15Revenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
March 2, 2027
EPS Estimate
-$0.16
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 46.83% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 3.47%▼ 59.49% |
|---|---|
| Total Invested | $29.96M▼ 95.38% |
| Investors Holding | 48▼ 171.00% |
About Sana Biotechnology Inc
265 employees
Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. Sana shares a vision of repairing and controlling genes, replacing missing or damaged cells, and making its therapies broadly avai...